Lotus Bio-Technology Development Corp. Stock Analysis LBTD
Lotus Bio-Technology Development Corp. engages in improving healthcare and advancing diagnostics through technology development and market acquisition. The company is headquartered in Costa Mesa, California. The company went IPO on 2013-03-14. The firm delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.
Read More Lotus Bio-Technology Development Corp (LBTD) Chart
Financial Metrics & Statements of Lotus Bio-Technology Development Corp (LBTD)
FAQ's for Lotus Bio-Technology Development Corp (LBTD)
- According to Musaffa’s Shariah screening methodology, Lotus Bio-Technology Development Corp (LBTD) is currently classified as NOT COVERED as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Alternate Halal Stocks for Lotus Bio-Technology Development Corp (LBTD)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.